DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Viatris
Viatris
Q1 Pharma Sector Snapshot
Combination Medications
Big Pharma Freshens Up
Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Inc
Proxy Statement 2021
February 2021 EPS Pipeline Report
FDA Listing of Authorized Generics As of July 1, 2021
Drugs@FDA) for Information on All FDA Approved Drug Products, Including Labeling and Review Information
SCIENCE Japan Suspends 1.63M Moderna Doses
PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
Viatris Group Company Jurisdiction of Incorporation Legal Address Pfizer
Analysis to Aid Public Comment
The Five Best Covid-19 Stocks to Buy Now
Top 50 Companies Article Pack a Year of Surprises Shakes up Industry Top 10 Sandoz, Mylan and Teva Switch Places at the Top
FDA Sets Stage to Authorize Moderna's Covid-19 Vaccine
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
1 August 13, 2021 Viatris Inc. Report on U.S. Opioid Abuse On
Current Sustaining Member Companies
Top View
VIATRIS Q2 2021 Earnings
Viatris Annual Report 2021
REVATIO (Sildenafil) Tablets, for Oral Use
Mylan Sign-On Letter
Viatris Inc. and Atomo Diagnostics Announce Agreement with Unitaid to Expand Access to HIV Self-Test
United States Securities and Exchange Commission Form 11-K the Retirement and Savings Plan for Amgen Manufacturing, Limited Amge
How Will Deals Done Now Deliver What the Health Ecosystem Needs Next? 2020 EY M&A Firepower Report Ey.Com/Lifesciences Contents
Earnings Presentation
Retina Anti-VEGF Biosimilars: How to Prepare for the Coming Wave
Download Investment Profile
Viatris Investor Day Presentation
In the United States District Court for the District of Delaware
Overview of Ftc Actions in Pharmaceutical Products and Distribution*
United States Securities and Exchange Commission Form
Viatris Faqs to Pfizer Shareholders
Current Sustaining Member Companies
Mylan and Pfizer Announce Viatris As the New Company Name in the Planned Mylan-Upjohn Combination
February 2021 Pipeline Report
Vaccines and Therapies from OPPI Member Companies to Support the Country in Its Fight Against COVID-19 VACCINES
VIATRIS 2020 Sustainability Report
MYLAN N.V. (Exact Name of Registrant As Specified in Its Charter)
Industry Update Eagle Pharma.Xlsx
The Future Is Clear Valeant Annual Report 2010 Company Overview Valeant Pharmaceuticals International, Inc
Mrna COVID-19 Vaccines Do Not Increase the Short-Term Risk of Clinical Relapses in Multiple Sclerosis
PFE-2020-Form-10K-FINAL.Pdf
2019 GLOBAL SOCIAL RESPONSIBILITY REPORT OUR MISSION at Mylan, We Are Committed to Setting New Standards in Healthcare
William P. Deni, Jr. J. Brugh Lower GIBBONS PC One
Fujifilm Kyowa Kirin Biologics and Mylan EPD Announce Launch of “Adalimumab (Genetical Recombination) [Adalimumab Biosimilar 1]” in Japan
Viatris Reveals Branding to Reflect New Company's Transformative Strategy